These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19755947)

  • 1. Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization?
    Deltondo JA; Helm KF
    G Ital Dermatol Venereol; 2009 Aug; 144(4):441-4. PubMed ID: 19755947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
    Feldman SR; Fleischer AB
    Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
    Puviani M; Barcella A; Milani M
    G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinic keratosis as a marker of field cancerization in excision specimens of cutaneous malignancies.
    Lanoue J; Chen C; Goldenberg G
    Cutis; 2016 Jun; 97(6):415-20. PubMed ID: 27416085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New dermoscopic pattern in actinic keratosis and related conditions.
    Cuellar F; Vilalta A; Puig S; Palou J; Salerni G; Malvehy J
    Arch Dermatol; 2009 Jun; 145(6):732. PubMed ID: 19528439
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.
    Miola AC; Castilho MA; Schmitt JV; Marques MEA; Miot HA
    An Bras Dermatol; 2019; 94(6):698-703. PubMed ID: 31789247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
    Karagece Yalçin U; Seçkın S
    Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spreading pigmented actinic keratosis: a review.
    Uhlenhake EE; Sangueza OP; Lee AD; Jorizzo JL
    J Am Acad Dermatol; 2010 Sep; 63(3):499-506. PubMed ID: 20334953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
    Basset-Seguin N
    Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is tenderness a reliable predictor for differentiating squamous cell carcinomas from actinic keratoses?
    Cook BA; Gravely AA; Nelson DB; Warshaw EM
    J Am Acad Dermatol; 2011 Jul; 65(1):211-2. PubMed ID: 21679820
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beyond actinic keratoses: Field cancerization of the skin].
    Reygagne P; Rostain G
    Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes.
    Anwar J; Wrone DA; Kimyai-Asadi A; Alam M
    Clin Dermatol; 2004; 22(3):189-96. PubMed ID: 15262304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinic keratosis on a continuum with squamous cell carcinoma.
    Hurwitz RM; Buckel LJ
    Arch Dermatol; 2010 Aug; 146(8):923-4. PubMed ID: 20713835
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging drugs for actinic keratosis.
    Ulrich M; Drecoll U; Stockfleth E
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinic keratosis is squamous cell carcinoma.
    Lober BA; Lober CW
    South Med J; 2000 Jul; 93(7):650-5. PubMed ID: 10923948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited.
    Fernandez Figueras MT
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():5-7. PubMed ID: 28263020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical management of actinic keratosis and field cancerisation.
    Stockfleth E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization.
    Rossi A; Garelli V; Pranteda G; Cardone M; Anzalone A; Fortuna MC; Di Nunno D; Mari E; De Vita G; Carlesimo M
    J Photochem Photobiol B; 2016 Sep; 162():72-76. PubMed ID: 27344021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.
    Zalaudek I; Giacomel J; Schmid K; Bondino S; Rosendahl C; Cavicchini S; Tourlaki A; Gasparini S; Bourne P; Keir J; Kittler H; Eibenschutz L; Catricalà C; Argenziano G
    J Am Acad Dermatol; 2012 Apr; 66(4):589-97. PubMed ID: 21839538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.